Stay updated with breaking news from Regenxbio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of REGENXBIO Inc. (NASDAQ:RGNX – Get Free Report) fell 2% on Thursday . The stock traded as low as $21.67 and last traded at $21.74. 19,963 shares traded hands during mid-day trading, a decline of 97% from the average session volume of 791,242 shares. The stock had previously closed at $22.18. Wall Street Analysts […] ....
REGENXBIO Inc. (NASDAQ:RGNX – Get Free Report) gapped down prior to trading on Wednesday after the company announced weaker than expected quarterly earnings. The stock had previously closed at $20.02, but opened at $19.01. REGENXBIO shares last traded at $19.31, with a volume of 61,047 shares trading hands. The biotechnology company reported ($1.43) EPS for […] ....
REGENXBIO (NASDAQ:RGNX – Get Free Report) posted its quarterly earnings results on Tuesday. The biotechnology company reported ($1.43) earnings per share for the quarter, missing the consensus estimate of ($1.27) by ($0.16), Briefing.com reports. The firm had revenue of $22.30 million for the quarter, compared to the consensus estimate of $34.01 million. REGENXBIO had a […] ....
REGENXBIO (NASDAQ:RGNX – Get Free Report) issued its quarterly earnings data on Tuesday. The biotechnology company reported ($1.43) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.27) by ($0.16), Briefing.com reports. The firm had revenue of $22.30 million for the quarter, compared to analyst estimates of $34.01 million. REGENXBIO had a […] ....